verve therapeutics stock price prediction

VERV stock forecast. VERV analyst stock forecast price target and recommendation trends with in-depth analysis from research.

Are Jeff Brown Predictions For 2022 Legit Top 6 Exposed

According to analysts Verve Therapeuticss stock has a predicted upside of 5093 based on their 12-month price targets.

. VERV Verve Therapeutics Inc 1571 -007 -044 Compare Add to Watchlist. Verve Therapeutics has a 52. And has now fallen 3 days in a row.

Stock price fell by -692 on the last day Friday 6th May 2022 from 1417 to 1319. The stock has a 50-day moving average price of 2038 and a 200 day moving average price of 3053. Stock Price Forecast The 6 analysts offering 12-month price forecasts for Verve Therapeutics Inc have a median target of 5300 with a high estimate of 8600 and a low estimate of 3400.

Δ 5 Yr. Verve Therapeutics has been rated by Royal Bank of Canada and Stifel Nicolaus in the past 90 days. Verve Therapeutics Inc Stock Price Forecast VERV Predictons for2021.

5 rows The average VERVE THERAPEUTICS stock price prediction forecasts a potential upside of 28437 from. Log In Free. Ad When you sign up youll reveal the names and ticker symbols of these 5 companies.

Get a real-time Verve Therapeutics Inc. The Verve Therapeutics Inc. Summary of all time highs changes and price drops for Verve Therapeutics.

Δ 1 Yr. What analysts cover Verve Therapeutics. Our latest prediction for Verve Therapeutics Incs stock price was made on the March 9 2022 when the stock price was at 2888.

1 day and price target of 1567 USD. 43 rows About the Verve Therapeutics Inc stock forecast As of 2022 May 06 Friday current price of. This suggests a possible upside of 2775 from the stocks current price.

During that period the price should oscillate between -1273 and 1174. VERV stock price quote with breaking news financials statistics charts and more. How ARK Invests Big Idea Predictions Performed From 2017-2022 922AM ET 2072022 Seeking Alpha.

Free current stock price quotes and data for Verve Therapeutics Inc VERV. VERV stock quote history news and other vital information to help you with your stock trading and investing. Find the latest Verve Therapeutics Inc VERV stock price forecast 12-month price target predictions and analyst recommendations.

Guggenheim Cuts Verve Therapeutics Price Target to 64 From 84 Maintains Buy Rating. Find the latest Verve Therapeutics Inc. 7 equities research analysts have issued twelve-month price targets for Verve Therapeutics stock.

During the day the stock fluctuated 961 from a day low at 1270 to a day high of 1392. Skip to main content. The price has fallen in 6 of the last 10 days and is down by -2011 for this period.

Find out why it could still go higher. Compare VERV Stock to Peers. 614 31153 upside.

Their forecasts range from 3400 to 9200. The average rating for VERV stock is Buy The 12-month stock price forecast is 614 which is an increase of 31153 from the latest price. Find the latest Verve Therapeutics Inc.

On average they expect Verve Therapeutics stock price to reach 6233 in the next twelve months. Ad The stock this analyst recommended keeps going up. 2 weeks Verve Therapeutics Inc share price prediction for 2022-06-28 with daily closed price projections.

This analysts last stock recommendation jumped over 300 in 4 weeks. A rare market phenomena could change everything and theres no telling when it will occur. Verve Therapeutics Inc Price VERV Daily Price Prediction Charts.

Research news charts stock market performance and earnings. In the short term 2weeks VERVs stock price should underperform the market by -282. As a group analysts forecast that Verve Therapeutics will post -262 EPS for the current fiscal year.

Forecast for Tue 28 Jun 2022 price 885 Verve Therapeutics Inc stock price forecast for further price development up to 097 time horizon. The stock was purchased at an average price of 2138 per share with a.

Verve Therapeutics Inc Verv Stock Price Quote News Stock Analysis

Verve Therapeutics Stock Forecast Down To 0 000001 Usd Verv Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis